These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3561578)

  • 21. [Assessment of intraperitoneal drug distribution during intraperitoneal chemotherapy using saline-injected MR imaging through an implanted catheter-port system].
    Obuchi M; Shimizu A; Fujiwara T; Sugimoto H; Honda M; Kubota H; Yamamoto W; Kinebuchi Y
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1891-5. PubMed ID: 11729482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to give peritoneal chemotherapy.
    Doane LS; Fischer LM; McDonald TW
    Am J Nurs; 1990 Apr; 90(4):58-64. PubMed ID: 2321681
    [No Abstract]   [Full Text] [Related]  

  • 23. Intraperitoneal chemotherapy complicated by erosion of a Tenckhoff catheter into the colon.
    Holt RW; Petrilli ES; Evans SR; Ahlgren JD
    South Med J; 1989 Jul; 82(7):914-6. PubMed ID: 2749364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Care of ovarian cancer treated with intraperitoneal chemotherapy].
    Meng FH
    Zhonghua Hu Li Za Zhi; 1994 Jan; 29(1):24-6. PubMed ID: 7788741
    [No Abstract]   [Full Text] [Related]  

  • 25. [Intraperitoneal Chemotherapy--a new treatment method of ovarian cancer patients].
    Menczer J; Brenner H
    Harefuah; 1985 Oct; 109(7-8):202-4. PubMed ID: 4076921
    [No Abstract]   [Full Text] [Related]  

  • 26. Distribution of intraperitoneal chemotherapy into the pleural cavity.
    Vaccarello L; Berghella V; Rubin SC; Hoskins WJ
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):714-7. PubMed ID: 9205461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term access to the peritoneal cavity in ovarian cancer patients.
    Rubin SC; Hoskins WJ; Markman M; Hakes T; Lewis JL
    Gynecol Oncol; 1989 Apr; 33(1):46-8. PubMed ID: 2703166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma.
    Arts HJ; Willemse PH; Tinga DJ; de Vries EG; van der Zee AG
    Gynecol Oncol; 1998 Apr; 69(1):32-5. PubMed ID: 9570995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erosion of an intraperitoneal chemotherapy catheter resulting in an enterovaginal fistula.
    Ghosh K; Geller MA; Twiggs LB
    Gynecol Oncol; 2000 May; 77(2):327-9. PubMed ID: 10785489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Totally implantable venous access system in longterm chemotherapy.
    Dauplat J; Condat P; Giraud B
    Int Surg; 1985; 70(3):251-2. PubMed ID: 3938980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A modified technique for insertion of intraperitoneal port for chemotherapy.
    Liou WS; Teng NN; Chan JK
    J Surg Oncol; 2005 Jun; 90(4):247-8. PubMed ID: 15906367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understand the benefits and risks of intraperitoneal therapy for advanced ovarian cancer.
    Oestreicher P
    ONS Connect; 2007 Apr; 22(4):24-5. PubMed ID: 17477008
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intraperitoneal treatment of tumors of the ovary].
    Wendling C; Dufour P; Oberling F
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):241-7. PubMed ID: 2071869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients.
    Gadallah MF; Tamayo A; Sandborn M; Ramdeen G; Moles K
    Adv Perit Dial; 2000; 16():233-6. PubMed ID: 11045301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal therapy via the Tenckhoff catheter. Prevention and management of complications.
    Zook-Enck D
    J Intraven Nurs; 1990; 13(6):375-82. PubMed ID: 2243310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Petru E; Benedicic Ch; Huell A
    Gynecol Oncol; 2006 Jul; 102(1):129; author reply 130. PubMed ID: 16600354
    [No Abstract]   [Full Text] [Related]  

  • 37. Challenges of IP chemotherapy for ovarian cancer.
    Anselmo-Murphy AM
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
    Kehoe SM; Williams NL; Yakubu R; Levine DA; Chi DS; Sabbatini PJ; Aghajanian CA; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2009 May; 113(2):228-32. PubMed ID: 19254808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of protrusion of an intraperitoneal chemotherapy catheter through rectum.
    Bilsel Y; Balik E; Bugra D; Yamaner S; Akyuz A
    Int J Gynecol Cancer; 2005; 15(1):171-4. PubMed ID: 15670314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates.
    Landrum LM; Gold MA; Moore KN; Myers TK; McMeekin DS; Walker JL
    Gynecol Oncol; 2008 Feb; 108(2):342-7. PubMed ID: 17988721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.